Publication | Closed Access

Combination of Rituximab and Intravenous Immunoglobulin for Recalcitrant Ocular Cicatricial Pemphigoid

Ocular DiseaseVitreous BodyOphthalmologyIntravenous ImmunoglobulinImmunologyGlaucomaOcular PathologyMedicineOcular Tissue